Literature DB >> 2571304

Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium.

J M Baraban1, P F Worley, S H Snyder.   

Abstract

Most models of psychotropic drug action have emphasized effects on the release or uptake of neurotransmitters as well as interactions with receptors. Stimulation of neurotransmitter receptors triggers a complex array of electrical and biochemical actions. Recent experimental advances have greatly clarified the second messenger systems underlying neurotransmitter actions, suggesting novel sites of action for psychotropic agents. The authors emphasize the phosphoinositide system and the implications of its involvement for the therapeutic actions of lithium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571304     DOI: 10.1176/ajp.146.10.1251

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  14 in total

Review 1.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Early prediction of response to Vorinostat in an orthotopic rat glioma model.

Authors:  Li Wei; Samuel Hong; Younghyoun Yoon; Scott N Hwang; Jaekeun C Park; Zhaobin Zhang; Jeffrey J Olson; Xiaoping P Hu; Hyunsuk Shim
Journal:  NMR Biomed       Date:  2012-02-02       Impact factor: 4.044

3.  Pharmacological reversal of synaptic plasticity deficits in the mouse model of fragile X syndrome by group II mGluR antagonist or lithium treatment.

Authors:  Catherine H Choi; Brian P Schoenfeld; Aaron J Bell; Paul Hinchey; Maria Kollaros; Michael J Gertner; Newton H Woo; Michael R Tranfaglia; Mark F Bear; R Suzanne Zukin; Thomas V McDonald; Thomas A Jongens; Sean M J McBride
Journal:  Brain Res       Date:  2010-11-12       Impact factor: 3.252

4.  Inositol has behavioral effects with adaptation after chronic administration.

Authors:  H Cohen; M Kotler; Z Kaplan; M A Matar; O Kofman; R H Belmaker
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences.

Authors:  Rachael M Youngs; Melissa S Chu; Edward G Meloni; Alipi Naydenov; William A Carlezon; Christine Konradi
Journal:  J Neurosci       Date:  2006-05-31       Impact factor: 6.167

6.  Effect of lithium maintenance therapy on thyroid and parathyroid function.

Authors:  M Kusalic; F Engelsmann
Journal:  J Psychiatry Neurosci       Date:  1999-05       Impact factor: 6.186

7.  Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder.

Authors:  S L Dubovsky; M Thomas; A Hijazi; J Murphy
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

8.  Decreased agonist-stimulated Ca2+ response in neutrophils from patients under chronic lithium therapy.

Authors:  U Förstner; M Bohus; P J Gebicke-Härter; B Baumer; M Berger; D van Calker
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

9.  Chronic lithium attenuates dopamine D1-receptor mediated increases in acetylcholine release in rat frontal cortex.

Authors:  E Acquas; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

Review 10.  Long-term responsiveness to lithium as a pharmacogenetic outcome variable: treatment and etiologic implications.

Authors:  Firoza Mamdani; Iris Jaitovich Groisman; Martin Alda; Gustavo Turecki
Journal:  Curr Psychiatry Rep       Date:  2003-12       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.